New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 8, 2014
08:04 EDTCERE, BAYRYCeres licenses Persephone genome application to Bayer CropScience
Ceres (CERE) announced that the company has licensed its Persephone genome visualization application to Bayer (BAYRY) CropScience. The multi-year software license and collaboration agreement provides a non-exclusive license to Bayer as well as professional services including support, customizations and maintenance. Bayer is the second multi-national life sciences company to license Persephone as its primary genome browser.
News For CERE;BAYRY From The Last 14 Days
Check below for free stories on CERE;BAYRY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
05:57 EDTBAYRYBayer reports Q2 net income EU 953M vs. EU 841M last year
Subscribe for More Information
05:55 EDTBAYRYBayer says Stivargahas approved in Europe for GIST
Subscribe for More Information
July 29, 2014
07:42 EDTCERESenate Budget Committee to hold a hearing
The Committee holds a hearing entitled, "The Costs of Inaction: The Economic & Budgetary Consequences of Climate Change" which examines how failing to mitigate the risks associated with climate change will impact the U.S. federal budget. Participants include President Lubber of Ceres at the hearing being held on July 29 at 10 am. Webcast Link
July 28, 2014
07:18 EDTCERECeres to expand sorghum and sugarcane development in Brazil
Ceres will enhance its product development programs in Brazil and expand its development activities in biotech traits for sorghum and sugarcane over the next four years. The programs will now be funded in part under the Brazilian government's PAISS Agricola initiative, which promotes agricultural innovations in sugarcane as well as other energy crops. Under the PAISS program, Ceres is eligible for a multi-year credit facility of up to approximately $34M, at a government-subsidized, preferential interest rate. The company was also awarded approximately $4.5M, in the form of non-repayable grants to be drawn over four years. Ceres expects to complete the application and grant award process by the end of the calendar year.
July 25, 2014
07:32 EDTBAYRYAmerican Veterinary Medical Association to hold a conference
Subscribe for More Information
05:35 EDTBAYRYBayer, Onyx reports NEXAVAR Phase 3 trial did not meet primary endpoint
Subscribe for More Information
July 24, 2014
13:06 EDTBAYRYBayer treatment for systemic sclerosis receives FDA orphan designation
Subscribe for More Information
07:12 EDTBAYRYEvogene announces amendment to Bayer wheat agreement
Subscribe for More Information
July 21, 2014
07:14 EDTBAYRYAmerican Association of Physicists in Medicine to hold annual meeting
56th Annual Meeting of AAPM to be held in Austin, Texas on July 20-25.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use